| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Addex Therapeutics Ltd (SW: ADXN)
ADXN Technical Analysis
3
| As on 21st Nov 2025 ADXN STOCK Price closed @ 0.06 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.06 & Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADXNSTOCK Price
| Open | 0.06 | Change | Price | % |
| High | 0.06 | 1 Day | 0.00 | 0.00 |
| Low | 0.06 | 1 Week | 0.00 | 0.00 |
| Close | 0.06 | 1 Month | 0.00 | 0.00 |
| Volume | 292722 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.07 | 52 Week Low 0.05 | ||||
SW Switzerland Most Active Stocks
| CSGN | 0.82 | 0.00% |
| CSGN | 0.82 | 0.00% |
| UBSG | 29.77 | -1.94% |
| UBSG | 29.77 | -1.94% |
| NESN | 80.77 | 1.94% |
| NESN | 80.77 | 1.94% |
| NOVN | 102.88 | 2.45% |
| NOVN | 102.88 | 2.45% |
| ABBN | 54.62 | -1.83% |
| ABBN | 54.62 | -1.83% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
| ADXN Daily Charts |
ADXN Intraday Charts |
Whats New @ Bazaartrend |
ADXN Free Analysis |
|
|
ADXN Important Levels Intraday
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
ADXN Forecast November 2025
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.07 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | 0.05 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.04 |
ADXN Weekly Forecast
| 4th UP Forecast | 0.08 |
| 3rd UP Forecast | 0.07 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | 0.05 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.04 |
ADXN Forecast2025
| 4th UP Forecast | 0.12 |
| 3rd UP Forecast | 0.1 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.08 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | 0.03 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | 0 |
Addex Therapeutics Ltd ( SW Switzerland Symbol : ADXN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADXN Business Profile
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot?Marie?Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Address: Chemin des Mines, 9, Geneva, Switzerland, 1202
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service